Global Spinal Devices Market 2021 Industry Perspective, Comprehensive Analysis and Forecast 2026
MarketsandResearch.biz has published a market research study on
Global Spinal Devices Market Growth 2021-2026 which aims to deliver a complete and in-detail study of the market using the primary or secondary resource and various research tools. The report maps the growth trajectory of the global Spinal Devices market by accurately evaluating all the vital factors that have a positive impact on the market growth. The report elaborately explains the fundamental reason behind the tremendous growth and development of the market. The market weakness, opportunities, strength, and risk analysis provide a holistic picture of the market growth and development. This market is expected to attain vigorous momentum in its growth during the forecast period from 2021 to 2026.
Regeneron, Roche injectable antibody drug shows efficacy in preventing Covid-19
A Regeneron Pharmaceuticals antibody cocktail currently authorized for treating Covid-19 now has additional clinical data showing it reduces the risk of infection spread. The drug developer, along with partner Roche, plan to ask regulators to expand the drug’s authorization to include disease prevention.
Shares0
A Covid-19 antibody cocktail developed by Regeneron Pharmaceuticals and Roche has pivotal clinical trial data showing it protected against the spread of infection among people in the same household. The results support use of the drug as a preventative measure in a formulation that’s easier for both physicians and patients.
MedCity News
Microsoft builds out cloud healthcare business with $19.7B Nuance acquisition
Microsoft will buy up healthcare AI partner Nuance for $19.7 billion. Nuance makes speech-recognition tools for clinical documentation, as well as security tools.
Shares0
Nuance’s Dragon Ambient eXperience system is installed in a clinic. The voice recognition system automatically populates clinicians’ notes. Photo credit: Nuance
Microsoft is acquiring voice recognition company Nuance Communications as it competes with other cloud companies for a share of the healthcare market.
It plans to buy the company for a total of $19.7 billion in an-all cash deal, including Nuance’s debt. The deal was priced at $56 per share, up 23% from Nuance’s closing price on Friday.
Brad Howard
Brad Howard is a Certified Professional Coder (CPC), Medical Auditor (CPMA) and Hematology/Oncology Coder (CHONC) who has worked in the inpatient, outpatient, emergency room and ambulatory surgery care settings over the last 20 years. With McKesson, his team supports outpatient practices with billing, coding and clinical documentation improvement initiatives. Brad enjoys providing education to physicians, non-physician practitioners, and practice administrators on topics meant to maximize reimbursement while mitigating audit risk, such as improving progress note composition, increasing specificity in diagnosis code selection, benchmarking Evaluation and Management services, and ensuring compliance with Incident-To billing guidelines. Brad lives in The Woodlands, Texas, with Kara, his wife of 23 years, and his son, Andrew, along with Toby, his German shepherd.
Get the latest industry news first when you subscribe to our daily newsletter.
We will never sell or share your information without your consent. See our privacy policy.